MedTrace Logo

Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura

NCT04905654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-05-17

No results posted yet for this study

Summary

To investigate the migraine inducing effect of levcromakalim in patients with migraine with aura.

Conditions

  • Headache, Migraine
  • Aura

Interventions

DRUG

Levcromakalim

To investigate the role of levcromakalim compared with placebo in migraine with aura patients

DRUG

Saline

To investigate the role of levcromakalim compared with placebo in migraine with aura patients

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Messoud Ashina · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2023-05-16
Completion
2023-05-16

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04905654 on ClinicalTrials.gov